{"schema_version":"secwatch.filing_event.v1","accession":"0001099219-26-000048","form_type":"8-K","ticker":"MET","cik":"0001099219","company_name":"METLIFE INC","filed_at":"2026-08-05T20:31:29+00:00","discovered_at":"2026-08-05T20:33:10.358046+00:00","generated_at":"2026-08-05T20:33:44.222472+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MetLife Q2 adjusted EPS $2.43 (+20% YoY); announces $3B buyback authorization","bullets":["Adjusted EPS $2.43, up 20% YoY; net income $705M ($1.09 per share).","Premiums, fees & other revenues up 7% to $13.7B; net investment income up 18% to $6.7B.","Group Benefits adj. earnings up 25% to $503M; Asia up 21% to $420M; Latin America up 15% to $268M.","Board authorized new $3.0B share repurchase program; returned over $1.1B to shareholders in Q2.","Adjusted ROE 17% for second straight quarter, at top of 15-17% target range."],"urls":{"canonical":"https://secwatch.observer/filing/0001099219-26-000048","json":"https://secwatch.observer/filing/0001099219-26-000048.json","markdown":"https://secwatch.observer/filing/0001099219-26-000048.md","text":"https://secwatch.observer/filing/0001099219-26-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/0001099219-26-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/met-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:33:44.222472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}